Xylem stock took a hit Tuesday after the water technology company slashed its annual earnings outlook and warned that delayed projects and increasingly cautious customer spending were weighing on demand.
Shares of Xylem fell 12% to $95.26, making it the worst performer in the S&P 500 for the session. The stock is down 30% in 2026, putting it on track for its worst yearly performance on record, according to Dow Jones Market Data.
The company, which provides equipment and technology for water treatment, distribution, and wastewater management, posted third-quarter adjusted earnings of $1.44 a share and revenue of $2.2 billion on Tuesday. Those figures fell just short of consensus calls for adjusted earnings of $1.45 a share and revenue of $2.28 billion, according to FactSet.
The biggest weakness was Xylem's water monitoring and measurement business, where revenue declined 16% year over year, or 5% organically, as customers held off on new investments.
Those challenges aren't expected to ease anytime soon, prompting Xylem to lower its full-year outlook.
Xylem now expects full-year revenue of $8.95 billion, down from its previous forecast of $9.2 billion. It also cut its adjusted earnings outlook to between $5.40 and $5.45 a share, from $5.55 to $5.70 previously. Organic revenue is now expected to be flat, compared with an earlier forecast for growth of 2% to 3%.
The company also announced plans to sell two of its businesses as part of a broader restructuring aimed at accelerating growth. Xylem plans to consolidate its operations from four business segments to three starting in 2027.
Xylem has emerged as a beneficiary of the artificial-intelligence boom, as the construction of data centers fuels demand for equipment used to move, treat, and manage water. Orders from data centers in Xylem's Applied Water business surged more than 200% year over year in the third quarter.
Still, the business is a relatively small part of Xylem's operations. CEO Matthew Pine said in an earnings call Tuesday that data centers are expected to account for about 2% of the company's annualized revenue by the end of 2026.
There were signs of resilience elsewhere. Orders increased 10% organically to $2.3 billion, suggesting that demand for Xylem's products and services remains intact even as customers postpone investments.
Comments